CSI Market
Sign In | Register

Evofem Biosciences Inc (EVFM) Annual Balance Sheets

Annual · GAAP · USD millions
Access EVFM quarterly Balance Sheets →
Observing balance sheet movements over recent quarters helps explain how Evofem Biosciences Inc adapts its asset base and funding mix.
View historic periods: Download as CSV:
Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.
Annual Report, GAAP in USD millions
ITEM 		(Dec 31 2025)
(Dec 31 2024) (Dec 31 2023) (Dec 31 2022) (Dec 31 2021)
Assets
Cash & cash equivalent0.58
Cash & Short-term Investments0.00
Accounts receivable12.48
Inventories1.13
Other Current Assets0.00
Prepaid Expense And Other Assets Current1.10
Total Current Assets15.28
Equipment/Property/Plant Net0.42
Intangible Assets4.35
Other Assets, Noncurrent0.22
Restricted Cash Current-
Operating Lease Right Of Use Asset0.18
Total Assets20.27
Liabilities
Accounts Payable, Current AC13.15
Accrued Liabilities, Current3.88
Derivative Liability, Current DE1.01
Short-term Debt DE10.15
Other Liabilities, Current66.64
Total Current Liabilities84.82
Total Long-term Debt0.00
Other liabilities, Noncurrent4.89
OperatingLeaseLiabilityNoncurrent0.05
Operating Lease Liability Current0.13
Contingent Liabilities Current0.27
Total Liabilities89.71
Stockholders' Equity
Common Stock Value0.01
Additional Paid In Capital Common Stock831.86
Retained Earnings / Accumulated Deficit-897.39
Other Equity-13.72
Common Stockholder's Equity-79.24
Non-controlling interests & other4.90
Total Stockholder's Equity-74.34
Liabilities & Stockholder's Equity20.27
4 historic quarters locked

Sign in to unlock the full Evofem Biosciences Inc balance sheet history.

Sign In Create Free Account

About Evofem Biosciences Inc Annual Balance Sheet

What this statement shows

This page presents issuer-reported balance sheet data, detailing assets, liabilities, and stockholders equity as reported in SEC 10-K filings and standardized by CSIMarket. The balance sheet reflects the company's financial position at the end of each reporting period.

Source & verification

  • Form: 10-K (Period: 20251231)
  • Filed with the SEC: March 11, 2026
  • Source: form10-k.htm

Last updated

  • Page updated:
  • Data lineage: SEC filings - XBRL extraction - balance-sheet normalization in the CSIMarket.com financial database.
  • Accession: 0001493152-26-009686

Balance sheet figures represent financial position at specific reporting dates and may be revised in subsequent filings.

Get the full CSIMarket dataset: Subscribe API License